Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Duchene’s muscular dystrophy: a clinical case

View through CrossRef
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the most common and pronounced forms of muscular dystrophy associated with the X chromosome on a recessive feature and belongs to the class “Dystrofinopathy”. Dystrophinopathy develops in the hereditary absence of a membrane protein of dystrophin, which is responsible for the integrity of the muscle cell cytoskeleton. MDD develops quite slowly and is asymptomatic at an early stage. In the subsequent course of the disease there are severe lesions of skeletal and respiratory muscles, heart, delayed psycho -language development and organic lesions of the nervous system. Multiple insufficiency in such patients causes high rates of early mortality. Aim. The purpose of the work is to describe a clinical case of a rare Duchene muscle dystrophy disease with a patient who was treated with a regional clinical hospital with a more detailed study of pathomorphological changes in this pathology. Methods. The material for the study was a clinical case of Duchene's muscular dystrophy in a patient who died in the Emergency Medical Assistance Department of the KNP Choir "Regional Clinical Hospital" in Kharkiv with a clinical diagnosis: Duchene's muscular dystrophy. The patient's medical history and the autopsy protocol were studied. Histological examination was performed using the following painting methods: hematoxylin-eosin, van Gizon, Congo red, Perls reaction. Results. Autopsy revealed the following pathomorphological changes: lesions of skeletal muscles - scoliosis, pseudogipertrophy of the calf muscles; respiratory damage and cardiomyopathy pathology, which have led to the development of decompensated right ventricular heart failure in the patient. Conclusion. MDD is a rare progressive disease that is inherited with dystrophin protein deficiency. Pathology occurs in early childhood and leads to muscle tissue. Most patients die from pulmonary - heart failure. In this case, the pathomorphological changes that occur in this disease are described.
Title: Duchene’s muscular dystrophy: a clinical case
Description:
Background.
Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles.
Duchene's muscular dystrophy (MDD) is one of the most common and pronounced forms of muscular dystrophy associated with the X chromosome on a recessive feature and belongs to the class “Dystrofinopathy”.
Dystrophinopathy develops in the hereditary absence of a membrane protein of dystrophin, which is responsible for the integrity of the muscle cell cytoskeleton.
MDD develops quite slowly and is asymptomatic at an early stage.
In the subsequent course of the disease there are severe lesions of skeletal and respiratory muscles, heart, delayed psycho -language development and organic lesions of the nervous system.
Multiple insufficiency in such patients causes high rates of early mortality.
Aim.
The purpose of the work is to describe a clinical case of a rare Duchene muscle dystrophy disease with a patient who was treated with a regional clinical hospital with a more detailed study of pathomorphological changes in this pathology.
Methods.
The material for the study was a clinical case of Duchene's muscular dystrophy in a patient who died in the Emergency Medical Assistance Department of the KNP Choir "Regional Clinical Hospital" in Kharkiv with a clinical diagnosis: Duchene's muscular dystrophy.
The patient's medical history and the autopsy protocol were studied.
Histological examination was performed using the following painting methods: hematoxylin-eosin, van Gizon, Congo red, Perls reaction.
Results.
Autopsy revealed the following pathomorphological changes: lesions of skeletal muscles - scoliosis, pseudogipertrophy of the calf muscles; respiratory damage and cardiomyopathy pathology, which have led to the development of decompensated right ventricular heart failure in the patient.
Conclusion.
MDD is a rare progressive disease that is inherited with dystrophin protein deficiency.
Pathology occurs in early childhood and leads to muscle tissue.
Most patients die from pulmonary - heart failure.
In this case, the pathomorphological changes that occur in this disease are described.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Background: Facioscapulohumeral dystrophy (FSHD) is a rare hereditary disease with a prevalence of 2.03–6.8 per 100,000 individuals. FSHD is the third most common type of muscular ...
Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
Muscular Atrophy (MA) and Muscular dystrophy (MD) diseases are genetic diseases. These diseases are commonly diagnosed with the help of techniques such as chorionic villus sampling...
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
Abstract A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few w...
Cell Therapy for Muscular Dystrophy
Cell Therapy for Muscular Dystrophy
Muscular dystrophy is a major unmet medical need associated with an inevitable progressive muscle damage and loss of function. Currently, treatment is only symptomatic and supporti...
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized an...
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
It is well known that muscular dystrophy disease severity is controlled by genetic modifiers. The expectation is that by identifying these modifiers, we can illuminate additional t...

Back to Top